Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2014; 20(41): 15163-15176
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15163
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15163
Table 1 Reviews obtained from the search into “probiotics”
| Probiotics | Author's conclusions | Ref. |
| Treating acute infectious diarrhea | Beneficial effects | [109] |
| Prevention of pediatric antibiotic associated diarrhea | Evidence of a protective effect | [110] |
| Treating persistent diarrhea in children | Limited evidence | [111] |
| Treatment of Clostridium difficile (C. difficile)-associated colitis in adults | Insufficient evidence | [112] |
| Prevention of C. difficile-associated diarrhea in adults and children | Moderate quality evidence | [113] |
| Prevention of necrotizing enterocolitis in preterm infants | Prevents severe necrotizing enterocolitis | [114] |
| Induction of remission in ulcerative colitis | Limited evidence | [115] |
| Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis | Probiotic VSL#3 was more effective than placebo | [116] |
| Maintenance of remission in ulcerative colitis | Insufficient evidence | [117] |
| Maintenance of remission in Crohn's disease | No evidence | [118] |
| Induction of remission in Crohn's disease | Insufficient evidence | [119] |
| Prevention of post-operative recurrence of Crohn's disease | Insufficient randomized trials | [120] |
| Non-alcoholic fatty liver disease and/or steatohepatitis | Lack of randomized clinical trials | [121] |
| Patients with hepatic encephalopathy | Need of efficacy demonstration | [122] |
| Treatment of bacterial vaginosis | No sufficient evidence | [123] |
| Preventing preterm labour | Insufficient data | [124] |
| For prevention of allergic disease and food hypersensitivity (in infants) | Insufficient evidence | [125] |
| Treating eczema | No effective treatment | [126] |
| Preventing acute upper respiratory tract infections | Limited evidence | [127] |
Table 2 Some Bifidobacterium strains tested in human intervention studies showing positive effects on gastrointestinal functions
| Bifido species | Bifido strain | Other species | Reported effect | Ref. |
| B. animalis subs. lactis | Bb12 | + S. thermophilus | Antibiotic associated diarrhoea–children | [129] |
| No | Prevent infection in child care centres | [130] | ||
| + L. rhamnosus (GG and Lc705), P. freudenreichii ssp. shermani JS | Alleviate symptoms of IBS | [131] | ||
| DN-173010 | + S. thermophilus, L. delbureckii subsp. bulgaricus, L. lactis (= fermented milk) | Improve symptoms of IBS | [132,133] | |
| Improve GI well-being in women with minor digestive symptoms | [134,135] | |||
| Affect brain activity (emotion and sensation) in healthy women | [136] | |||
| HN019 | No | Improve functional GI symptoms in adults | [137] | |
| B. bifidum | NCDO 1453 | + L. acidophilus NCDO 1748 | Prevent NEC in very low birth weight preterm infants | [138] |
| B. breve | Bb99 | + L. rhamnosus (GG and Lc705), P. freudenreichii ssp. shermani JS | Alleviate symptoms of IBS | [139] |
| Yakult | + prebiotic GOS | Improve clinical conditions of patients with UC | [140] | |
| + L. casei Shirota | Improve symptoms and decrease H2 production in lactose-intolerant patients | [141] | ||
| B. infantis | 35624 | No | Alleviate symptoms of IBS | [142] |
| No | Relive symptoms of IBS in woman | [143] | ||
| No | Reduce systemic pro-inflammatory biomarkers in GI and no-GI conditions | [144] | ||
| Infloran® (B. infantis) | Unknown | + L. acidophilus | Prevent NEC in very low birth weight preterm infants | [145] |
| ABC Dophilus (B. infantis, B. bifidus) | Unknown | + S. thermophilus | Prevent NEC in very low birth weight neonates | [146] |
| VSL#3® (B. breve, B. infantis, B. longum) | Unknown | + S. thermophilus, L. acidophilus, L. plantarum, L. paracasei, L. delbrueckii subsp. bulgaricus | Remission of UC in children | [147] |
| Ameliorate symptoms in children with IBS | [148] | |||
| Reduce symptoms in mild to moderate UC patients | [149,150] | |||
| Maintain remission in recurrent or refractory pouchitis | [151,152] | |||
| Reduce the pouchitis activity index in IPAA patients | [153] | |||
| Reduce the incidence of AAD in risk hospital inpatients | [154] |
- Citation: Tojo R, Suárez A, Clemente MG, de los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P. Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World J Gastroenterol 2014; 20(41): 15163-15176
- URL: https://www.wjgnet.com/1007-9327/full/v20/i41/15163.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i41.15163
